Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-01-23
2007-01-23
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252180, C514S274000, C514S275000, C540S601000, C544S122000, C544S315000, C544S316000, C544S331000
Reexamination Certificate
active
10362146
ABSTRACT:
Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R1, R2, and R4are various substituent groups, are protein kinase inhibitors
REFERENCES:
patent: 4200750 (1980-04-01), Warner et al.
patent: 4576952 (1986-03-01), Hurst et al.
patent: 4621089 (1986-11-01), Ward et al.
patent: 4670432 (1987-06-01), Ward et al.
patent: 4985444 (1991-01-01), Shiokawa et al.
patent: 5155114 (1992-10-01), Shiokawa et al.
patent: 5204346 (1993-04-01), Shiokawa et al.
patent: 5234930 (1993-08-01), Shiokawa et al.
patent: 5236934 (1993-08-01), VanAtten
patent: 5246943 (1993-09-01), Blankley et al.
patent: 5296490 (1994-03-01), Shiokawa et al.
patent: 5300478 (1994-04-01), Michaely et al.
patent: 5498774 (1996-03-01), Mitsudera et al.
patent: 5521213 (1996-05-01), Prasit et al.
patent: 5534518 (1996-07-01), Henrie et al.
patent: 5552422 (1996-09-01), Gauthier et al.
patent: 5658903 (1997-08-01), Adams et al.
patent: 5700816 (1997-12-01), Isakson et al.
patent: 5858995 (1999-01-01), Kawai et al.
patent: 5932576 (1999-08-01), Anantanarayan et al.
patent: 5945418 (1999-08-01), Bemis et al.
patent: 5977103 (1999-11-01), Adams et al.
patent: 5990148 (1999-11-01), Isakson et al.
patent: 6087496 (2000-07-01), Anantanarayan et al.
patent: 6130235 (2000-10-01), Mavunkel et al.
patent: 6136839 (2000-10-01), Isakson et al.
patent: 6147080 (2000-11-01), Bemis et al.
patent: 6174887 (2001-01-01), Haruta et al.
patent: 6207675 (2001-03-01), Carry et al.
patent: 6251914 (2001-06-01), Adams et al.
patent: 6277989 (2001-08-01), Chakravarty et al.
patent: 6436925 (2002-08-01), Lubisch et al.
patent: 6451794 (2002-09-01), Beswick et al.
patent: 6498166 (2002-12-01), Campbell et al.
patent: 6509361 (2003-01-01), Weier et al.
patent: 6509363 (2003-01-01), Salituro et al.
patent: 6579872 (2003-06-01), Brown et al.
patent: 6638980 (2003-10-01), Su et al.
patent: 6756498 (2004-06-01), Fitzgerald et al.
patent: 6774127 (2004-08-01), Adams et al.
patent: 6855719 (2005-02-01), Thomas et al.
patent: 6919352 (2005-07-01), Chamberlain et al.
patent: 6962914 (2005-11-01), Gudmundsson et al.
patent: 2001/0011135 (2001-08-01), Reidl et al.
patent: 2004/0038858 (2004-02-01), Dorsch et al.
patent: 2004/0176446 (2004-09-01), Alonso-Alija et al.
patent: 2004/0242868 (2004-12-01), Angell et al.
patent: 2004/0249161 (2004-12-01), Angell et al.
patent: 2004/0266839 (2004-12-01), Angell et al.
patent: 2004/0267012 (2004-12-01), Angell et al.
patent: 2005/0020540 (2005-01-01), Angell et al.
patent: 2005/0020590 (2005-01-01), Lang et al.
patent: 2005/0038014 (2005-02-01), Angell et al.
patent: 2005/0065195 (2005-03-01), Angell et al.
patent: 2005/0090491 (2005-04-01), Angell et al.
patent: 0 404 190 (1990-06-01), None
patent: 0 404 190 (1990-06-01), None
patent: 0 379 979 (1990-08-01), None
patent: 0 467 248 (1991-07-01), None
patent: 0 497 258 (1992-01-01), None
patent: 0 533 266 (1992-09-01), None
patent: 0 533 268 (1992-09-01), None
patent: 0 346 841 (2003-06-01), None
patent: 0 430 033 (2004-04-01), None
patent: 2 757 059 (1998-06-01), None
patent: 2 276 161 (1993-03-01), None
patent: 2 276 162 (1993-03-01), None
patent: 2 273 930 (1993-12-01), None
patent: 2 295 387 (1996-05-01), None
patent: EP 0 364 204 (1989-10-01), None
patent: WO 91/00092 (1991-01-01), None
patent: WO 91/19497 (1991-12-01), None
patent: WO 94/15920 (1994-07-01), None
patent: WO 95/00501 (1995-01-01), None
patent: WO 95/06636 (1995-03-01), None
patent: WO 95/06644 (1995-03-01), None
patent: WO 95/11243 (1995-04-01), None
patent: WO 95/15954 (1995-06-01), None
patent: WO 95/17401 (1995-06-01), None
patent: WO 95/29907 (1995-11-01), None
patent: WO 95/30675 (1995-11-01), None
patent: 96/06840 (1996-03-01), None
patent: WO 96/21667 (1996-07-01), None
patent: 96/31509 (1996-10-01), None
patent: WO 96/31508 (1996-10-01), None
patent: WO 96/41625 (1996-12-01), None
patent: WO 96/41626 (1996-12-01), None
patent: WO 96/41645 (1996-12-01), None
patent: WO 97/03034 (1997-01-01), None
patent: 98/56377 (1998-12-01), None
patent: WO 98 56377 (1998-12-01), None
patent: 99/12930 (1999-03-01), None
patent: WO 99/32463 (1999-07-01), None
patent: 99/58523 (1999-11-01), None
patent: WO 99/59585 (1999-11-01), None
patent: WO 99/64419 (1999-12-01), None
patent: WO 00/12074 (2000-03-01), None
patent: WO 00/12497 (2000-03-01), None
patent: 00/26216 (2000-05-01), None
patent: 00/52008 (2000-09-01), None
patent: WO 00/56738 (2000-09-01), None
patent: WO 00/71493 (2000-11-01), None
patent: WO 00/71509 (2000-11-01), None
patent: WO 00/71510 (2000-11-01), None
patent: WO 00/71511 (2000-11-01), None
patent: WO 01/00615 (2001-01-01), None
patent: 01/14375 (2001-03-01), None
patent: WO 01/27089 (2001-04-01), None
patent: WO 01/34605 (2001-05-01), None
patent: WO 01/70695 (2001-09-01), None
patent: WO 01/83479 (2001-11-01), None
patent: WO 01/87875 (2001-11-01), None
patent: WO 02/16359 (2002-02-01), None
patent: WO 02/18382 (2002-03-01), None
patent: WO 02/40486 (2002-05-01), None
patent: WO 02/48147 (2002-06-01), None
patent: WO 02/48148 (2002-06-01), None
patent: WO 02/66481 (2002-08-01), None
patent: WO 03/000682 (2003-01-01), None
patent: WO 03/032970 (2003-04-01), None
patent: WO 03/068747 (2003-08-01), None
patent: WO 03/093248 (2003-11-01), None
patent: WO 04/010995 (2004-02-01), None
patent: WO 04/089874 (2004-10-01), None
patent: WO 04/089875 (2004-10-01), None
patent: WO 04/089876 (2004-10-01), None
patent: WO 05/014550 (2005-02-01), None
patent: WO 05/061465 (2005-07-01), None
Laszio et al., Pyrroles and other heterocycles as inhibitors of p38 kinase, Bioorganic & Medicinal Chemistry Letters, 8(19), pp. 2689-2694 (1998).
Layzer, Degenerative Diseases of the Nervous System, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 2050-2057, 1996.
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.
Damasio, Alzheimer's Disease and Related Dementias, Cecil Textbook of Medicine, 20thEdition, vol. 2, Jun. 1992, 1996.
Boehm et al., “1-Substituted 4-Aryl-5pyridinylimidazoles: A New Class of Cytokine Suppressive Drugs with Low 5-Lipoxygenase and Cyclooxygenase Inhibitory Potency,”Journal of Medicinal Chemistry, American Chemical Society, Washington, US, vol. 39, 20 (Sep. 27, 1996), pp. 3929-3937.
Hanson, G.J., “Inhibitors of p38 kinase,”Expert Opinion on Therapeutic Patents, Ashley Publications, GB, vol. 7, No. 7, pp. 729-733, 1997.
Boehm et al.,Expert Opinion of Therapeutic Patents, vol. 10 (1) pp. 25-37 (2000).
Ceccarelli et al.,European Journal of Medicinal Chemistry, vol. 33 (12) pp. 943-955 (1998).
Gabriele et al.,European Journal of Organic Chemistry, vol. 2001 (24) pp. 4607-4613 (2001).
Han et al.,Biohemica et Biophysica Acta—Molecular Cell Researchvol. 1265 (2-3) pp. 224-227 (1995.
Henry et al.,Drugs of the Future, vol. 24 (12) pp. 1345-1354 (1999).
Jiang et al,Journal of Biological Chemistry, vol. 271 (30) pp. 17920-17926 (1996).
Li et al.,Biochemical and Biophysical Research Communications, vol. 228 (2) pp. 334-340 (1996).
Liebeskind et al.,Organic Letters, vol. 4 (6) pp. 979-981 (2002).
Moreland et al.,Annals of Internal Medicine, vol. 130 (6) pp. 478-486 (1999).
Murali Dhar et al.,Bioorganic and Medicinal Chemistry Letters, vol. 12 (21) pp. 3125-3128 (2002).
Rankin et al.,British Journal of Rheumatology, vol. 34 pp. 334-342 (1995).
Salituro et al.,Current Medicinal Chemistry, vol. 6 pp. 807-823 (1999).
Wang et al.,Journal of Biological Chemistry, vol. 272 (38) pp. 23668-23674 (1997).
Akahane, Atsushi, “Discovery of 6-Oxo-3-(2-Phenlypyrazolo[1,5-a]pyridin-3-yl)-1(6H)-pyridazinebutanoic Acid (FR 838): A Novel Xanthine Adenosine A1Receptor Antagonist with Potent Diuretic Activity,”Journal of Medicinal Chemistry, vol. 42, No. 5, 1999, pp. 779-783.
Bosseray et al., Pub Med Abstract (Pathol Biol (Paris) 50(8):483-92) Oct. 2002.
Carter, J. et al. “Recently Reported Inhibitors of Cyclooxygenase-2.” Exp. Opin. Ther. Patents (1998), 8(1), pp. 21-29.
Douglas, Jr. Introduction to Viral Diseases, Cecil Textbook of Me
Alberti Michael John
Badiang Jennifer Gabriel
Baldwin Ian Robert
Cheung Mui
Cockerill Stuart
Glaxo Group Limited
Morgan Lorie Ann
LandOfFree
Fused pyrazole derivatives being protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused pyrazole derivatives being protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused pyrazole derivatives being protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3724598